EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gene-Editing and RNA Interference in Treating Hepatitis B: A Review

Nadiia Kasianchuk iD, Krystyna Dobrowolska iD, Sofiia Harkava iD, Andreea Bretcan, Dorota Zarębska-Michaluk iD, Jerzy Jaroszewicz, Robert Flisiak iD, Piotr Rzymski iD

Viruses · 08.12.2023 · 15 (12) · 2395

DOI: 10.3390/v15122395 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 08.12.2023. Verfasst von Nadiia Kasianchuk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, Adam Mickiewicz University in Poznań, 61-614 Poznań, Poland. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B, Chronic. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hepatitis B virus (HBV) continues to cause substantial health and economic burdens, and its target of elimination may not be reached in 2030 without further efforts in diagnostics, non-pharmaceutical prevention measures, vaccination, and treatment. Current therapeutic options in chronic HBV, based on interferons and/or nucleos(t)ide analogs, suppress the virus replication but do not eliminate the pathogen and suffer from several constraints. This paper reviews the progress on biotechnological approaches in functional and definitive HBV treatments, including gene-editing tools, i.e., zinc-finger proteins, transcription activator-like effector nucleases, and CRISPR/Cas9, as well as therapeutics based on RNA interference. The advantages and challenges of these approaches are also discussed. Although the safety and efficacy of gene-editing tools in HBV therapies are yet to be demonstrated, they show promise for the revitalization of a much-needed advance in the field and offer viral eradication. Particular hopes are related to CRISPR/Cas9; however, therapeutics employing this system are yet to enter the clinical testing phases. In contrast, a number of candidates based on RNA interference, intending to confer a functional cure, have already been introduced to human studies. However, larger and longer trials are required to assess their efficacy and safety. Considering that prevention is always superior to treatment, it is essential to pursue global efforts in HBV vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis BHepatitis B, ChronicHumansRNA InterferenceCRISPR-Cas SystemsGenetic TherapyDNA, ViralHepatitis B virusAntiviral Agents

Stichwörter der Autor:innen

CRISPR/CasRNA interferenceTALENsantiviralshepatitis BmRNA vaccinestherapeutic vaccinations

Substanzen

DNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • Faculty of Biology, Adam Mickiewicz University in Poznań, 61-614 Poznań, Poland.
  • Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland.
  • Junior Academy of Sciences of Ukraine, Regional Branch in Dnipro, 49000 Dnipro, Ukraine.
  • National College "Ienăchiță Văcărescu", 130016 Târgoviște, Romania.
  • Department of Infectious Diseases and Allergology, Jan Kochanowski University, 25-317 Kielce, Poland.
  • Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.

ORCID-Profile: Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, Dorota Zarębska-Michaluk, Robert Flisiak, Piotr Rzymski

Zitieren

APA

Kasianchuk, N., Dobrowolska, K., Harkava, S., Bretcan, A., Zarębska-Michaluk, D., Jaroszewicz, J., Flisiak, R., & Rzymski, P. (2023). Gene-Editing and RNA Interference in Treating Hepatitis B: A Review. Viruses, 15(12), 2395. https://doi.org/10.3390/v15122395

Vancouver

Kasianchuk N, Dobrowolska K, Harkava S, Bretcan A, Zarębska-Michaluk D, Jaroszewicz J, et al. Gene-Editing and RNA Interference in Treating Hepatitis B: A Review. Viruses. 2023;15(12):2395. doi:10.3390/v15122395

BibTeX
@article{Kasianchuk2023,
  author = {Kasianchuk, Nadiia and Dobrowolska, Krystyna and Harkava, Sofiia and Bretcan, Andreea and Zarębska-Michaluk, Dorota and Jaroszewicz, Jerzy and Flisiak, Robert and Rzymski, Piotr},
  title = {Gene-Editing and RNA Interference in Treating Hepatitis B: A Review},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {12},
  pages = {2395},
  doi = {10.3390/v15122395}
}
Kostenlos starten →